Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of publishing details of plans to offer second doses of a covid-19 vaccine to young people aged 12 to 17 years who are not (a) at increased risk from infection or (b) living with someone who is immunosuppressed.

The Joint Committee on Vaccination and Immunisation, the independent body which advises the Government on vaccination use and prioritisation, will be reviewing data on second doses for 16 to 17 year olds this autumn. A review of second doses for young people aged 12 to 15 years old will follow, once more data on second doses in this age group is available internationally.